study	individual	group	count	intervention	time	time_unit	x_measurement_type	x_substance	x_tissue	x_method	x_label	x	x_sd	x_unit	y_measurement_type	y_tissue	y_method	y_label	y	y_mean_pm	y_sd	y_se	y_unit	comments
Kreutz2017	NA	all	24	api	156	hr	concentration	apixaban	plasma	LC MS/MS	api_apixaban_plasma_vs_mean_Anti-factor Xa activity_ug	40.4914566031498	14.9	ug/l	Anti-factor Xa activity	plasma	coagulation assay	api_Anti-factor Xa activity_vs_apixaban_mean_ug	37.5	NA	5.5875	1.14054366148342	ug/l	NA
Kreutz2017	NA	all	24	api	168	hr	concentration	apixaban	plasma	LC MS/MS	api_apixaban_plasma_vs_mean_Anti-factor Xa activity_ug	52.981314958175	19.6	ug/l	Anti-factor Xa activity	plasma	coagulation assay	api_Anti-factor Xa activity_vs_apixaban_mean_ug	44.9	NA	9.6086	1.96134726187554	ug/l	NA
Kreutz2017	NA	all	24	api	180	hr	concentration	apixaban	plasma	LC MS/MS	api_apixaban_plasma_vs_mean_Anti-factor Xa activity_ug	12.7114251264887	5.6	ug/l	Anti-factor Xa activity	plasma	coagulation assay	api_Anti-factor Xa activity_vs_apixaban_mean_ug	26.8	NA	2.4254	0.495082701845527	ug/l	NA
